Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer’s disease
Shao Li, Dong Chen, Deqin Geng, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 2, pp. 329-341
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer's disease
Dhanshree Jha, Erik N.T.P. Bakker, Rahul Kumar
Journal of Neurochemistry (2023)
Open Access | Times Cited: 23
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
Anna Chiarini, Li Gui, C Viviani, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 999-999
Open Access | Times Cited: 23
Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer’s Disease and Regulation by Natural Plant Products
Runru Zu, Lu Hao, Wanting Liu, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Ginkgolide B regulates apoptosis, oxidative stress, and mitochondrial dysfunction in MPP+-induced SK-N-SH cells by targeting HDAC4/JNK pathway
Ding Xu, Dongming Tan, Zhao Wang, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 20
Nanomedicines for Alzheimer's disease: Therapies based on pathological mechanisms
Guowang Cheng, Aihua Xie, Zhao Yan, et al.
Brain‐X (2023) Vol. 1, Iss. 3
Open Access | Times Cited: 17
Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer’s Disease
Mingzhenlong Deng, Wanli Yan, Zhicheng Gu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1486-1486
Open Access | Times Cited: 16
Ginkgolide B effectively mitigates neuropathic pain by suppressing the activation of the NLRP3 inflammasome through the induction of mitophagy in rats
Jing-Hao Liang, Heng Yu, Chuanpeng Xia, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117006-117006
Open Access | Times Cited: 6
Autophagy Balances Neuroinflammation in Alzheimer’s Disease
Xuehua Cheng, Yong Wei, Zijun Qian, et al.
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 4, pp. 1537-1549
Closed Access | Times Cited: 23
Correction to “Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease”
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access
Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
Jung Lo, Ching‐Chih Liu, Yueh-Shan Li, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 5347-5359
Open Access | Times Cited: 22
Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
Dan Chen, Yun Sun
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 1
Open Access
Unlocking the Therapeutic Potential of Natural Products for Alzheimer’s Disease
Zhonghua Li, Zhenqiang Zhang, Bin Yu
Journal of Medicinal Chemistry (2025)
Closed Access
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access
NLRP3 inflammasome in Alzheimer’s disease: molecular mechanisms and emerging therapies
Zhitao Li, Cheng Gong
Frontiers in Immunology (2025) Vol. 16
Open Access
The roles of ubiquitination and deubiquitination of NLRP3 inflammasome in inflammation-related diseases: A review
Shaokai Tang, Yuanwen Geng, Yawei Wang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 4, pp. 708-721
Open Access | Times Cited: 3
Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
Tiago Siqueira de Sousa, Paula I. Moreira, Susana Cardoso
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2331-2331
Open Access | Times Cited: 8
A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer’s disease
Zhiyou Yang, Junxin Liu, Shuai Wei, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 7
Ginkgolide attenuates memory impairment and neuroinflammation by suppressing the NLRP3/caspase-1 pathway in Alzheimer’s disease
Guang-Zhi Liu, Tian-Tong Niu, Qian Yu, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 10237-10252
Open Access | Times Cited: 7
Ginkgolide B: mechanisms of neurobiological effects, prospects for use in the therapy of Alzheimer’s disease
М. А. Berezutsky, Н. А. Дурнова, Т. А. Андронова
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 4, pp. 22-22
Closed Access | Times Cited: 2
Comprehensive Exploration of the Neuroprotective Mechanisms of Ginkgo biloba Leaves in Treating Neurological Disorders
Q. Liu, Jinghui Wang, Zongyun Gu, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 04, pp. 1053-1086
Closed Access | Times Cited: 2
Review on dietary supplements as an effective improvement of Alzheimer’s disease: focus on structures and mechanisms
Sheng Li, Yinling Wei, Zhenzhen Liang, et al.
Deleted Journal (2023) Vol. 13, Iss. 4, pp. 1787-1805
Open Access | Times Cited: 4
NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer’s Disease
Shuqi Tao, Wenyuan Fan, Jinmeng Liu, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 4, pp. 1383-1398
Closed Access | Times Cited: 4
Ginkgolide B Blocks Vascular Remodeling after Vascular Injury via Regulating Tgfβ1/Smad Signaling Pathway
Quan Wang, Shuai Ni, Ling Li, et al.
Cardiovascular Therapeutics (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 4
Effect of ginkgo diterpene lactone meglumine on the quality of life in patients with acute ischemic stroke
Xue Tian, Qin Xu, Xue Xia, et al.
Health and Quality of Life Outcomes (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top